Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal mucosa protection" refers to the collective physiological and biochemical processes that maintain the integrity of the gastrointestinal mucosal barrier. This includes protection from mechanical injury, pathogens, toxins, and immune imbalances. The barrier is formed by a multilayered defense including mucus (produced mainly by goblet cells), tight epithelial junctions, immune mediators, and repair mechanisms. Disruptions to this protection can result in increased infection risk, chronic inflammation, and contribute to diseases such as inflammatory bowel disease and colorectal cancer[1][2][4][5]. Many molecular mechanisms underlie mucosal protection (e.g., mucus secretion, bicarbonate secretion, immune cell activity) but there is no single molecule known as "intestinal mucosa protection"[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosa protection.